Literature DB >> 24862743

Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.

Larisa J Geskin1, Oleg E Akilov, Yan Lin, Anna E Lokshin.   

Abstract

Immunological functions decline with age. Because MS/SzS predominately affects the elderly, it is important to distinguish age-related from cancer-specific changes. Also, MF and SzS are malignancies of CD4(+) T-lymphocytes, further compromising an immune state of the patients. The objectives of this study were to distinguish disease-specific immunological deterioration by performing comparative age-matched Luminex multiplex assessment of 34 serum biomarkers between patients with MF/SzS, HIV-infected individuals and normal controls. Controlling for age, expression level appears to significantly differ between patients with MF/SzS and controls for the following biomarkers: G-CSF, IL-5, MIP-1β, TNF-α, VEGF, EOTAXIN, IL-8, IL-12, IL-2R, IP10, MCP-1, MIG, TNFR1 and TNFR2 (P < 0.05), while others showed normal age-related changes. Interestingly, cluster analysis placed MF/SzS profiles closer to HIV. This further underscores an immunologically compromised state of patients with MF/SzS and suggests its potential self-perpetuating role in disease progression.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  age; biomarkers; cutaneous T-cell lymphoma; cytokines

Mesh:

Substances:

Year:  2014        PMID: 24862743      PMCID: PMC4125529          DOI: 10.1111/exd.12455

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  16 in total

Review 1.  The immune system in the elderly: III. Innate immunity.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; D Quaglino
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma.

Authors:  Tomomitsu Miyagaki; Makoto Sugaya; Hideki Fujita; Hanako Ohmatsu; Takashi Kakinuma; Takafumi Kadono; Kunihiko Tamaki; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2010-05-27       Impact factor: 8.551

3.  Dynamic alteration of soluble serum biomarkers in healthy aging.

Authors:  Galina V Shurin; Zoya R Yurkovetsky; Gurkamal S Chatta; Irina L Tourkova; Michael R Shurin; Anna E Lokshin
Journal:  Cytokine       Date:  2007-08-08       Impact factor: 3.861

4.  Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Ivan V Litvinov; Yang Wang; Lixin Xia; Andreas Willerslev-Olsen; Sergei B Koralov; Katharina L Kopp; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Anders Woetmann; Youwen Zhou; Denis Sasseville; Niels Odum
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

5.  Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris.

Authors:  J B Rottman; T L Smith; K G Ganley; T Kikuchi; J G Krueger
Journal:  Lab Invest       Date:  2001-03       Impact factor: 5.662

6.  Changing incidence trends of cutaneous T-cell lymphoma.

Authors:  Kaveri Korgavkar; Michael Xiong; Martin Weinstock
Journal:  JAMA Dermatol       Date:  2013-11       Impact factor: 10.282

7.  Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.

Authors:  Ivan V Litvinov; David A Jones; Denis Sasseville; Thomas S Kupper
Journal:  Clin Cancer Res       Date:  2010-03-16       Impact factor: 12.531

8.  Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.

Authors:  C P Tensen; M H Vermeer; P M van der Stoop; P van Beek; R J Scheper; D M Boorsma; R Willemze
Journal:  J Invest Dermatol       Date:  1998-08       Impact factor: 8.551

9.  Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.

Authors:  N Seo; Y Tokura; K Matsumoto; F Furukawa; M Takigawa
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

10.  Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  Arch Dermatol       Date:  2007-07
View more
  4 in total

1.  Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.

Authors:  Larisa J Geskin; Sara Viragova; Donna B Stolz; Patrizia Fuschiotti
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

Review 2.  The biomarker landscape in mycosis fungoides and Sézary syndrome.

Authors:  Brittany Dulmage; Larisa Geskin; Joan Guitart; Oleg E Akilov
Journal:  Exp Dermatol       Date:  2017-02-02       Impact factor: 3.960

Review 3.  Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.

Authors:  Sara Berg; Jennifer Villasenor-Park; Paul Haun; Ellen J Kim
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

4.  Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma.

Authors:  Randy Tang; Larisa Geskin; Marc E Grossman
Journal:  JAAD Case Rep       Date:  2015-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.